Clinically diagnosed hepatocellular carcinoma and hepatic hemangioma
Conditions
Interventions
Observation group:none
Sponsors
Army Medical Center of PLA
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Volunteers for the study; 2. Patients who have not received radiation or chemotherapy; 3. Clearly no extrahepatic metastasis; 4. All patients underwent radical surgical treatment; 5. Preoperative imaging diagnosed hepatic hemangioma or primary hepatocellular carcinoma, which was confirmed by postoperative pathological examination as hepatic hemangioma or primary hepatocellular carcinoma, with negative surgical margins.
Exclusion criteria
Exclusion criteria: 1. Individuals with mental illnesses; 2. Those with active hepatitis or other liver diseases such as fatty liver; 3. Individuals with other malignant tumors; 4. Those unable to tolerate surgery-related procedures; 5. Patients who have undergone preoperative radiotherapy, chemotherapy, interventional therapy, radiofrequency ablation, or immunotherapy; 6. Postoperative pathology indicating non-primary hepatocellular carcinoma; 7. Individuals with severe systemic diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| WB grayscale value;Expression level of PAMR1; | — |
Countries
China
Contacts
Public ContactChen Ping
Army Medical Center of PLA
Outcome results
None listed